NEW YORK , Dec. 20, 2022 (GLOBE NEWSWIRE) — The Nasdaq Stock Market announced today that it will delist the common stock of PhaseBio Pharmaceuticals, Inc. PhaseBio Pharmaceuticals, Inc.’s common stock was suspended on November 3, 2022 , and has not traded on Nasdaq since that time.
